Connect with us
[the_ad id="89560"]

Business

From ‘brilliant’ to ‘aghast’: Reactions to RFK Jr.’s nomination for HHS secretary run the gamut

Published

15 mins ago

12 minute read

From LifeSiteNews

By Dr. Brenda Baletti, The Defender

From “brilliant” to “aghast” – President-elect Donald J. Trump’s nomination on Thursday of Robert F. Kennedy Jr., founder of Children’s Health Defense (CHD), to run the U.S. Department of Health and Human Services (HHS) triggered a range of reactions among media outlets, public health officials, and Kennedy’s long-time supporters and detractors.

In a statement posted on Truth Social and X, Trump said Kennedy would restore the public health agencies “to the traditions of Gold Standard Scientific Research, and beacons of Transparency, to end the Chronic Disease epidemic, and to Make America Great and Healthy Again!”

Kennedy, who promised to fight corruption and end the revolving door between industry and government, thanked Trump for the nomination on social media. He said he would “free the agencies from the smothering cloud of corporate capture so they can pursue their mission to make Americans once again the healthiest people on Earth.”

 

Kennedy is a longtime critic of how corporate interests have captured the public health agencies meant to regulate them, and of the outsized and corrupt role that Big Pharma plays in American life.

If confirmed, Kennedy would hold the most powerful governmental position in public health, overseeing 80,000 employees across a department that houses 13 agencies and more than 100 programs. Those agencies include the Centers for Disease Control and Prevention (CDC), the U.S. Food and Drug Administration (FDA), the National Institutes of Health and the Center for Medicaid and Medicare Services.

CHD CEO Mary Holland told The Defender the organization “could not be more pleased” with the nomination, adding:

Kennedy has been devoted to ending the childhood chronic health epidemic for almost 20 years. He has been effective in communicating the failures of our existing public health establishment.

Based on his extensive litigation history, he is uniquely prepared to reform the regulatory institutions, the research institutions, and public education on health. I look forward to seeing dramatic, measurable improvements in Americans’ health during the Trump administration.

Democratic Colorado Gov. Jared Polis said on X that he was “excited by the news,” particularly about Kennedy’s commitment to fighting chemicals in foods, the power of Big Pharma, and to other health priorities.

“I hope he leans into personal choice on vaccines rather than bans (which I think are terrible, just like mandates) but what I’m most optimistic about is taking on big pharma and the corporate ag oligopoly to improve our health,” he added.

Rep. Chip Roy (R-Texas) told Fox News, “I think Robert is another disruptor. We need a disruptor. I will be glad and I’m looking forward to working with him,” Politico reported.

Sen. Ron Johnson (R-Wis.) called Kennedy a “brilliant, courageous truth-teller” and said he could make the “most significant impact on health.”

Vaccine stocks take a dive on news of announcement

On the flip side, some lawmakers and public health leaders expressed alarm, decrying the nomination.

U.S. Rep. Robert Garcia (D-Calif.) called the choice “f— insane” on X, Fox News reported. “He’s a vaccine denier and a tin foil hat conspiracy theorist. He will destroy our public health infrastructure and our vaccine distribution systems. This is going to cost lives.”

Dr. Richard E. Besser, CEO of the Robert Wood Johnson Foundation and a former acting director of the CDC, said that having Kennedy head up HHS “would pose incredible risks to the health of the nation,” because Kennedy’s critique of the public health agencies was worsening the mistrust lingering after the coronavirus pandemic, The New York Times reported.

Besser told CNN that some of Kennedy’s ideas about chronic health issues regarding children were good ideas, but other ideas were deeply concerning – particularly Kennedy’s proposal that individuals should decide for themselves whether to take a vaccine.

“The idea that receiving childhood vaccines would be a parental choice scares me,” he said.

READ: Canada’s public health agency still working to adopt WHO pandemic treaty: report

Current CDC Director Mandy Cohen raised concerns that Kennedy would use the position to spread misinformation and foster distrust in public health institutions, particularly with respect to vaccines.

Kennedy has called for an end to immunity for vaccine manufacturers for the injuries caused by their products. He points out that no vaccine on the childhood immunization schedule has undergone proper safety and efficacy testing.

He has been a long-term advocate for the tens of thousands of families seeking compensation for their children’s vaccine-induced autism.

Kennedy also promised that, if confirmed, he would make the V-safe vaccine injury data collected but not made public by the CDC transparent, so scientists have access to the data necessary to analyze vaccine safety

Vaccine and Pharma stocks fell sharply this morning, following yesterday’s announcement about Kennedy, Reuters reported.

 

Bavarian Nordic, which makes the mpox vaccine, was down 16 percent. Its CEO told Reuters he was concerned that Kennedy could fuel vaccine skepticism.

However, he also said that the U.S. response to the COVID-19 pandemic under Trump’s first term made him confident that the incoming administration would continue to fund biodefense.

The Trump administration launched and oversaw Operation Warp Speed, the public-private partnership to rapidly develop a COVID-19 vaccine that gave vaccine makers hundreds of billions in profits along with total immunity for any harms caused by those investigational vaccines under the Public Readiness and Emergency Preparedness (PREP) Act.

Kennedy will be ‘single greatest threat to profits in America’

Republican advisers have cautioned that Kennedy could face a difficult path to confirmation, The Washington Post reported, citing his “past statements on drugs and vaccines, and his many personal entanglements.” FiercePharma said his confirmation process is likely “to be contentious.”

Physician, professor and Substacker Dr. Vinay Prasad wrote that Trump could use a recess appointment to secure Kennedy’s position, but that he will likely need to be confirmed by the Senate where “He has a several hundred billion dollar industry that will do everything possible to stop him.”

“Many of these companies have lobbied throughout Congress,” Prasad added. “They will use those connections. Unlike other controversial appointees, RFK Jr. will be the single greatest threat to profits in America.”

If his appointment goes through, Prasad said Kennedy will face a difficult road in getting his proposed policies enacted, given the entrenched power of Pharma and the power of the media that opposes him.

Law professor Wendy Parmet, director of Northeastern University’s Center for Health Policy and Law, pointed to the potential clash between Kennedy’s anti-industry position and the big-business leanings of the Republican Party.

“We have an administration that promises to deregulate, to be business-friendly, and then we have RFK Jr., who promises to go after fast food,” Parmet told The Washington Post.

READ: Idaho health district votes to stop offering COVID vaccines at its medical centers

Health and health freedom advocates optimistic Kennedy will bring change

Despite the challenges ahead, health advocates are optimistic that changes they have been seeking for decades will come to pass.

During the COVID-19 pandemic, critics of pandemic policies were condemned and marginalized. Kennedy was censored by the Biden administration and social media companies as part of the so-called “Disinformation Dozen” for airing many of those critiques.

Over the course of the election Kennedy – who ran for president as a Democrat, then announced he was running as an independent before suspending his campaign and endorsing Trump – has repeatedly been called a “conspiracy theorist.” Both Kennedy and CHD are routinely dismissed as “anti-vax” for openly discussing the scientific evidence on the link between vaccines and chronic diseases including autism, attention-deficit/hyperactivity disorder or ADHD and other neuropsychiatric and autoimmune disorders, in some children.

Rather than investigating the science, mainstream media mostly insists these links have been “debunked,” without providing any evidence for their claim.

Kennedy has also called for the removal of fluoride from public drinking water, citing recent studies and a landmark federal court decision that show it interferes with children’s brain development – a concern that has even been flagged by some mainstream public health commentators.

His supporters hope these issues will now receive serious public attention that will lead to policy change.

Holland said on X that Kennedy’s nomination came 38 years to the day after the Vaccine Injury Act that gave vaccine manufacturers immunity from liability was signed into law.

“Let’s rewrite this one,” she said.

Before Post

Related Topics:

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

More from this author
Business / 15 mins ago

From ‘brilliant’ to ‘aghast’: Reactions to RFK Jr.’s nomination for HHS secretary run the gamut

COVID-19 / 2 hours ago

Dr. McCullough praises RFK Jr., urges him to pull COVID shots from the market

Health / 8 hours ago

Canada’s public health agency still working to adopt WHO pandemic treaty: report

Business

Ottawa’s avalanche of spending hasn’t helped First Nations

Published on November 19, 2024

By

From the Fraser Institute

By Tom Flanagan

When Justin Trudeau came to power in 2015, he memorably said that the welfare of Indigenous Canadians was his highest priority. He certainly has delivered on his promise, at least in terms of shovelling out money.

During his 10 years in office, budgeted Indigenous spending has approximately tripled, from about $11 billion to almost $33 billion. Prime Minister Trudeau’s instruction to the Department of Justice to negotiate rather than litigate class actions has resulted in paying tens of billions of dollars to Indigenous claimants over alleged wrongs in education and other social services. And his government has settled specific claims—alleged violations of treaty terms or of the Indian Act—at four times the previous rate, resulting in the award of at least an additional $10 billion to First Nations government.

But has this avalanche of money really helped First Nations people living on reserves, who are the poorest segment of Canadian society?

One indicator suggests the answer is yes. The gap between reserves and other communities—as measured by the Community Well-Being Index (CWB), a composite of income, employment, housing and education—fell from 19 to 16 points from 2016 to 2021. But closer analysis shows that the reduction in the gap, although real, cannot be due to the additional spending described above.

The gain in First Nations CWB is due mainly to an increase in the income component of the CWB. But almost all of the federal spending on First Nations, class-action settlements and specific claims do not provide taxable income to First Nations people. Rather, the increase in income documented by the CWB comes from the greatly increased payments legislated by the Liberals in the form of the Canada Child Benefit (CCB). First Nations people have a higher birth rate than other Canadians, so they have more children and receive more (on average) from the Canada Child Benefit. Also, they have lower income on average than other Canadians, so the value of the CCB is higher than comparable non-Indigenous families. The result? A gain in income relative to other Canadians, and thus a narrowing of the CWB gap between First Nations and other communities.

There’s an important lesson here. Tens of billions in additional budgetary spending and legal settlements did not move the needle. What did lead to a measurable improvement was legislation creating financial benefits for all eligible Canadian families with children regardless of race. Racially inspired policies are terrible for many reasons, especially because they rarely achieve their goals in practise. If we want to improve life for First Nations people, we should increase opportunities for Canadians of all racial backgrounds and not enact racially targeted policies.

Moreover, racial policies are also fraught with unintended consequences. In this case, the flood of federal money has made First Nations more dependent rather than less dependent on government. In fact, from 2018 to 2022, “Own Source Revenue” (business earnings plus property taxes and fees) among First Nations bands increased—but not as much as transfers from government. The result? Greater dependency on government transfers.

This finding is not just a statistical oddity. Previous research has shown that First Nations who are relatively less dependent on government transfers tend to achieve higher living standards (again, as measured by the CWB index). Thus, the increase in dependency presided over by the Trudeau government does not augur well for the future.

One qualification: this finding is not as robust as I would like because the number of band governments filing reports on their finances has drastically declined. Of 630 First Nation governments, only 260 filed audited statements for fiscal 2022. All First Nations are theoretically obliged by the First Nations Financial Transparency Act, 2013, to publish such statements, but the Trudeau government announced there would be no penalties for non-compliance, leading to a precipitous decline in reporting.

This is a shame, because First Nations, as they often insist, are governments, not private organizations. And like other governments, they should make their affairs visible to the public. Also, most of their income comes from Canadian taxpayers. Both band members and other Canadians have a right to know how much money they receive, how it’s being spent and whether it’s achieving its intended goals.

Author:

Tom Flanagan
Professor Emeritus of Political Science and Distinguished Fellow, School of Public Policy, University of Calgary
Continue Reading

Business

Companies Scrambling To Respond To Trump’s ‘Beautiful’ Tariff Hikes

Published on November 17, 2024

By

From the Daily Caller News Foundation 

By Adam Pack

Companies are scrambling to respond to President-elect Donald Trump’s “beautiful” tariff proposals that his administration may seek to enact early in his second term.

Proactive steps that companies are taking to evade anticipated price increases include stockpiling inventory in U.S. warehouses and weighing whether they need to completely eliminate China from their supply chains and raise the price of imported goods affected by tariff hikes, whose costs will be passed onto consumers.

Free-trade skeptics are touting companies’ anticipatory actions as delivering a clear sign that Trump’s proposed tariff hikes are already achieving their intended effect of pressuring retailers to eliminate China from their supply chains. However, some policy experts are warning that higher tariffs will be a regressive tax for America’s lower and middle-income families and make inflation worse, according to retailers and economists who spoke to the Daily Caller News Foundation.

On the campaign trail, Trump proposed a universal tariff of up to 20% on all imports coming into the U.S. and a 60% or higher tariff on all imports from China. Trump is considering Robert Lighthizer, the former U.S. trade representative during his administration’s first term who is well-known for favoring high tariffs, to serve as his second administration’s trade czar, the Wall Street Journal first reported.

‘Mitigation Strategies To Lessen The Impact’

Companies are taking preemptive measures, such as stockpiling goods in U.S. warehouses, to work proactively against anticipated price increases that higher tariffs would inflict, Jonathan Gold, vice president of supply chains and customs policy for the National Retail Federation, told the DCNF during an interview.

“They’re looking at different mitigation strategies to lessen the impact that they might feel from the tariffs,” Gold told the DCNF. “One of those strategies is to start looking at potentially bringing in cargo, bringing products earlier to get ahead of potential tariffs that Trump might put in place.”

Importing goods into the U.S. ahead of schedule leads to additional costs for retailers that will likely be passed onto consumers, but waiting to import goods from China after a 60% or higher tariff on Chinese imports goes into effect would be substantially more expensive, according to Gold.

A recent NRF study projected that Trump’s proposed tariff hikes on consumer products would cost American consumers an additional $46 billion to $78 billion a year.

“A tariff is a tax paid by the U.S. importer, not a foreign country or the exporter,” Gold said in a press release accompanying the study. “This tax ultimately comes out of consumers’ pockets through higher prices.”

Decoupling From China

Part of the rationale behind Trump’s tariff proposals is to force manufacturing jobs to return to the United States and pressure companies to completely eliminate China from their supply chains, according to Mark DiPlacido, policy advisor at American Compass.

“I hope in addition to stockpiling, they’re also looking at actually moving their supply chains out of China and ideally back to the United States,” DiPlacido told the DCNF.

“For a long time, the framing has been what is best for just increasing trade flows, regardless of the direction those flows are going. What that’s resulted in for the last 25 years is a flow of manufacturing, a flow of factories and a flow of jobs, especially solid middle class jobs out of the United States and across the world,” DiPlacido added.

But completely shifting production outside of China is not feasible for some retailers even if companies have taken further steps to diversify their supply chain for the past decade, according to Gold.

“It takes a while to make those shifts and not everyone is able to do that, Gold acknowledged. “Nobody has the [production] capacity that China does. Trying to find that within multiple countries is a challenge. And it’s not just the capacity, but the skilled workforce as well.”

In addition, companies who move production out of China to avoid a 60% tariff on imported goods from the nation could still get hit by a 20% across the board tariff if they move their supply chain to countries other than the United States, Gold and several economists told the DCNF.

“They’re talking about tariffs on imports for which there’s not a domestic producer to switch to,” Clark Packard, a research fellow on trade policy at the CATO institute, told the DCNF in an interview. “For example, we don’t make coffee in the United States, so why are we going to impose a tariff on coffee?”

“Who are we trying to protect?” he added.

Some economists are also pessimistic that the president-elect’s planned tariff hikes will ultimately bring jobs that moved overseas to cheaper labor markets back to the United States.

“What we actually saw from the 2018-2019 trade war was a decrease in manufacturing output and employment because of the tariffs,” Erica York, senior economist and research director of the Tax Foundation’s Center for Federal Tax Policy, told the DCNF in an interview. “It played out just like every economist predicted: higher costs for U.S. consumers, reduced output, reduced incomes for American workers, foreign retaliation that’s harmful.”

The president-elect’s proposed tariff hikes could also eliminate more jobs than those saved or created as a result of protecting domestic industries, such as the U.S. steel or solar manufacturing industries, that may benefit from higher tariffs on foreign competitors, Packard told the DCNF.

“It’s disproportionate — the cost that is passed onto the broader economy to protect a very small slice of U.S. employment,” Packard said. Trump’s 25% tariff on imported steel enacted during his first administration slightly increased employment in the U.S. steel industry, but each job that was maintained or created came at a cost of roughly $650,000 that likely killed jobs in other sectors forced to buy more expensive steel, according to Packard.

‘Bipartisan Recognition’

Despite tariffs’ potential to force companies to raise the price of goods they import into the United States, DiPlacido defended Trump’s proposed tariff hikes as essential to eliminating U.S. dependence on China for a variety of strategic goods and consumer products.

“We need to be able to manufacture a broad range of goods in the United States. And we need the job security and the economic security that a strong manufacturing industrial base provides,” DiPlacido said. “That’s going to be important to any future conflict or emergency that the United States may have with China or with anyone else.”

DiPlacido, citing Trump’s dominant electoral performance, also believes Trump has the “mandate” to carry out the tariff proposals he floated during the campaign.

“There’s a sort of a bipartisan recognition of the problem. Even the Biden administration kept almost all of Trump’s tariffs in place,” DiPlacido told the DCNF. “I think he has the political mandate, and that’s often a harder thing to get.”

However, some economists are questioning whether the thousands of dollars of projected costs that American families would be forced to pay as a result of these tariff hikes could create political backlash that has so far failed to materialize against Trump and Biden’s relatively similar trade policies.

“Voters were rightly pretty upset about price increases and inflation,” Packard told the DCNF. “We’re talking about utilizing a tool in tariffs that will increase relative prices.”

“Tariffs as a whole are a regressive tax,” Gold told the DCNF. “They certainly hit low and middle income consumers the hardest.”

Retailers are forecasting a decrease in demand for consumer products as a result of Trump’s tariff proposals, according to Gold.

The incoming Senate Republican leader has also notably criticized Trump’s proposed tariff hikes.

“I get concerned when I hear we just want to uniformly impose a 10% or 20% tariff on everything that comes into the United States,” Republican South Dakota Sen. John Thune, Senate GOP leader, said in August during a panel on agriculture policy in his home state. “Generally, that’s a recipe for increased inflation.”

Continue Reading

Trending

X